About: Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy
Creator	Alber, Monika Fong, Dominic Haspinger, Eva Mitterer, Manfred Petter, Christian Rauch, Simon
Source	Medline; PMC
abstract	BACKGROUND: Optimal management of patients with cancer during COVID-19 pandemic is still pending. METHODS: Our patients were advised to maintain their scheduled appointments, and planned cancer treatment was continued without unnecessary delays in an outpatient setting. Additional strict preventive infection measures were rapidly implemented at our outpatient department. When COVID-19 test became widely available, universal testing of healthcare workers and vigorous screening of all patients coming to our facility for COVID-19 infection were performed by SARS-CoV-2 real-time reverse transcription PCR on rhinopharyngeal swab. RESULTS: As of the data cut-off on 9 April 2020, a total of 156 oncology patients with a median age of 67 (range 26–86) years and 63 haematology patients (median age 69 years, range 23–89) were screened for COVID-19 during active cancer treatment. Prevalence (1.8%; 4/219) of COVID-19 in patients with cancer was significantly higher compared with a respective control group of asymptomatic counterparts (p=0.018). Outcomes of COVID-19 positive patients were good, with only one observed death due to progression of advanced metastatic disease. CONCLUSION: Our data indicate that continuation of anticancer treatment in epidemic areas during the COVID-19 pandemic seems to be safe and feasible, if adequate and strict preventive measures are vigorously and successfully carried out.
has issue date	2020-06-10(xsd:dateTime)
bibo:doi	10.1136/esmoopen-2020-000810
bibo:pmid	32527730
has license	cc-by-nc
sha1sum (hex)	54c1c5750146c09f02bad00e2e469577f6768a75
schema:url	https://doi.org/10.1136/esmoopen-2020-000810
resource representing a document's title	Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy
has PubMed Central identifier	PMC7292048
has PubMed identifier	32527730
schema:publication	ESMO Open
resource representing a document's body	covid:54c1c5750146c09f02bad00e2e469577f6768a75#body_text
is schema:about of	named entity 'patients' named entity 'Original research' named entity 'management of cancer' named entity 'heterogeneity' named entity 'thermometers' named entity 'SORA' named entity 'COVID' named entity 'infection' named entity 'Lombardy region' named entity 'higher risk' named entity 'isolation ward' named entity 'respiratory disease' named entity 'COVID' named entity 'quarantine' named entity 'antitumour' named entity 'COVID-19' named entity 'metastatic disease' named entity 'COVID' named entity 'tertiary care' named entity 'Hubei' named entity 'Italy' named entity 'follow-up' named entity 'infection' named entity 'follow-up' named entity 'metastatic' named entity 'infection' named entity 'median age' named entity 'Fisher's exact test' named entity 'medical care' named entity 'South Tyrol' named entity 'COVID-19 test' named entity 'drastic measures' named entity 'general population' named entity 'oncology' named entity 'telemedicine' named entity 'COVID-19 pandemic' named entity 'open access' named entity 'pancreas cancer' named entity 'healthcare professionals' named entity 'testing kits' named entity 'universal coverage' named entity 'intensive care unit' named entity 'COVID-19 pandemic' named entity 'disinfection' named entity 'COVID-19' named entity 'questionnaire' named entity 'hospital-associated' named entity 'outpatient department' named entity 'control group' named entity 'medical records' named entity 'South Tyrol' named entity 'tested for COVID-19' named entity 'South Tyrol' named entity 'targeted therapy' named entity 'coronavirus outbreak' named entity 'outpatient' named entity 'higher risk' named entity 'ICU' named entity 'chemotherapy' named entity 'asymptomatic' named entity 'pulse oximeter' named entity 'isolation ward' named entity 'COVID' named entity 'Ipsen' named entity 'Novartis' named entity 'immunosuppressive' named entity 'febrile' named entity 'clinical outcomes' named entity 'loss of taste' named entity 'SARS-CoV-2' named entity 'Robert Koch Institute' named entity 'infection' named entity 'study design' named entity 'COVID-19 pandemic' named entity 'reverse transcription PCR' named entity 'healthcare providers'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software